Pharmabiz2h
AiMED welcomes Centre's move onboarding members to make EPCMD functional
AiMED welcomes Centre's move onboarding members to make EPCMD functional: Our Bureau, New Delhi Friday, March 28, 2025, 16:30 ...
Pharmabiz1h
Immutep doses first patient in its TACTI-004 phase III clinical trial in first line non-small cell lung cancer
Sydney, Australia Friday, March 28, 2025, 18:00 Hrs [IST] ...
Pharmabiz2h
Andaman7 seeks $5 million to continue investment in pioneering technology
Now, Andaman7 is seeking investment to: Get $1 million licenses with top life science customers over the next two years. Finalise three AI features for its already innovative platform. Become the ...
Pharmabiz3h
Anixa Biosciences inks LoI with VERDI Solutions to develop artificial intelligence-guided personalized and off-the-shelf peptide vaccines for cancer
Anixa Biosciences inks LoI with VERDI Solutions to develop artificial intelligence-guided personalized and off-the-shelf peptide vaccines for cancer: San Jose, Calif Friday, March ...
Pharmabiz4h
Endometriosis is a chronic inflammatory condition caused due to abnormal appearance of the uterine lining. Dr Shilpa Singhal
Endometriosis is a chronic inflammatory condition caused due to abnormal appearance of the uterine lining. Dr Shilpa Singhal: Our Bureau, Chennai Friday, March 28, 2025, 14:30 Hrs ...
Pharmabiz4h
Sichuan Kelun-Biotech’s radionuclide-drug conjugate SKB107 receives China NMPA approval to treat bone metastases in solid tumours
Biotech’s radionuclide-drug conjugate SKB107 receives China NMPA approval to treat bone metastases in solid tumours: Chengdu, China Friday, March 28, 2025, 15:00 H ...
Pharmabiz5h
Veracyte’s new trial data shows accuracy in WGS-based MRD testing platform for muscle-invasive bladder cancer
South San Francisco, California Friday, March 28, 2025, 14:00 Hrs [IST] ...
Pharmabiz5h
NCLT approves Scheme of Amalgamation between Cohance Lifesciences and Suven Pharmaceuticals
NCLT approves Scheme of Amalgamation between Cohance Lifesciences and Suven Pharmaceuticals: Our Bureau, Bengaluru Friday, March 28, 2025, 14:15 Hrs [IST] Suven Pharmaceuticals a ...
Pharmabiz5h
BluHeat by Nysh.in launches innovative Cough Decongestion Patches with air activated technology
BluHeat by Nysh.in launches innovative Cough Decongestion Patches with air activated technology: Our Bureau, Bengaluru Friday, March 28, 2025, 13:45 Hrs [IST] Nysh.in, a pioneerin ...
Pharmabiz5h
USC-licensed startup NeOnc Technologies gets Nasdaq listing, unveils India clinical trial expansion
USC-licensed startup NeOnc Technologies gets Nasdaq listing, unveils India clinical trial expansion: Our Bureau, Bengaluru Friday, March 28, 2025, 13:30 Hrs [IST] A USC-licensed s ...
Pharmabiz7h
US FDA grants fast track designation to Sanofi’s mRNA vaccine candidate for prevention of chlamydia infection
US FDA grants fast track designation to Sanofi’s mRNA vaccine candidate for prevention of chlamydia infection: Paris Friday, March 28, 2025, 12:00 Hrs [IST] The US Food and Drug ...
Pharmabiz6h
Bayer, Puhe BioPharma ink global license agreement for clinical phase I PRMT5 inhibitor
Bayer, Puhe BioPharma ink global license agreement for clinical phase I PRMT5 inhibitor: Berlin, Germany Friday, March 28, 2025, 13:00 Hrs [IST] Bayer and Suzhou Puhe BioPharma Co ...